Diagnosis
If one can demonstrate major nerve damage
associated with the development of RSD / CRPS symptoms, the condition is
called complex regional pain syndrome (CRPS) type II or causalgia.
Generally, causalgia provides more objective evidence of disease due to
neurological changes (numbness and weakness).
The terms complex regional pain syndrome (CRPS) type I and type II
have been used since 1995, when the International Association for the
Study of Pain (IASP) felt the respective names reflex sympathetic
dystrophy and causalgia were inadequate to represent the full spectrum
of signs and symptoms.
The term "Complex" was added to convey the reality that RSD and
causalgia express varied signs and symptoms. Many publications,
particularly older ones, still use the names RSD and causalgia. To
facilitate communication and understanding the designation RSD / CRPS is
generally used throughout these practice guidelines. The principles
applicable to the diagnosis and management of RSD are similar to those
principles applicable to the diagnosis and management of causalgia.
To make the early diagnosis of RSD / CRPS, the practitioner must
recognize that some features/manifestations of RSD / CRPS are more
characteristic of the syndrome than others, and that the clinical
diagnosis is established by piecing each bit of the puzzle together
until a clear picture of the disorder emerges. Often the physician needs
to rule out other potentially life-threatening disorders that may have
clinical features similar to RSD / CRPS, e.g. a blood clot in a leg vein
or a breast tumor spreading to lymph glands can cause a swollen,
painful extremity. Indeed, RSD / CRPS may be a component part of another
disease, (e.g. a herniated disc of the spine, carpal tunnel syndrome of
the hand, heart attack). Thus, treating RSD / CRPS will often be
directed to treating clinical features rather than a well defined
disease. When RSD / CRPS spreads the diagnosis can be more complicated.
For example, if it spreads to the opposite limb, it may be more
difficult to establish a diagnosis because there is no normal side
(control) to compare for objective findings. On the other hand, the
spreading of RSD / CRPS symptoms may actually facilitate the diagnosis
of RSD / CRPS because spreading symptoms is a characteristic of the
disorder. (See below).
Importance of Objective Findings
Many patients who develop RSD / CRPS as the result
of an injury do so in the context of legal liability. Some patients can
be expected to defend their rights in courts of law. It is not uncommon
for the defendant to accuse the patient of faking their condition,
especially if there are no objective findings for RSD / CRPS documented
on the medical record. Therefore, the evaluating physician must assess
more than just subjective complaints (medical history). The physician
must aggressively seek and document
objective findings. For example, about 80% of RSD / CRPS cases have
differences in temperature in opposite sides that may be either colder
or warmer. These temperature changes may be associated with changes in
skin color. Furthermore, the temperature differences are not static. The
skin temperature can undergo dynamic changes in a relatively short
period of time (within minutes) depending critically on room
temperature, local temperature of the skin and emotional stress. In some
cases, the differences in temperatures may fluctuate spontaneously even
without any apparent provocation. 4
Thus, the objective finding of differences in temperature and color of
the skin can be missed by the physician if only a single physical
examination is made. A useful and relatively inexpensive instrument to
have available at the time of the physical examination is a portable
infrared thermometer to measure differences in skin temperature. Changes
in skin temperature and color are only two examples of several
objective findings that should be sought in the patients with RSD /
CRPS.
Making the Diagnosis of RSD / CRPS
The diagnosis of RSD / CRPS can be made in the
following context. A history of trauma to the affected area associated
with pain that is disproportionate to the inciting event plus
evidence at some time for one or more of the following:
- Abnormal function of the
sympathetic nervous system, e.g., abnormal changes in
skin blood flow, sweating or goose flesh.
- Swelling.
- Movement disorder.
- Changes in tissue growth (dystrophy and atrophy).
Thus patients do not have to meet
all of the clinical manifestations listed above to make the diagnosis
of RSD / CRPS. Note also that the criteria state "evidence at some time"
for the clinical findings. This does not mean that the evidence for the
clinical finding listed has to be constant. This explains why swelling,
abnormal sweating, abnormal skin temperatures, etc., are not reported
by the physician on some visits. Sometimes weather plays a factor or
emotional stress or the patient may be in a flare-up or a remission
stage. Patients have good and bad days.
The RSD / CRPS diagnosis is
precluded by the existence of known pathology that can be explained by
the observed symptoms and degree of pain. The pain and symptoms of RSD /
CRPS may exceed both the magnitude and duration of symptoms expected
from the normal healing process anticipated from the inciting event.
There seems to be a small group of patients whose pain following trauma
resolves over time, leaving the patient with more of a movement than a
pain disorder.
Clinical Features of RSD / CRPS
- Pain - The
hallmark of RSD / CRPS is pain and mobility problems out of proportion
to those expected from the initial injury. The first and primary
complaint occurring in one or more extremities is described as severe,
constant, burning and/or deep aching pain. All tactile stimulation of
the skin (e.g. wearing clothing, a light breeze) may be perceived as
painful (allodynia). Repetitive tactile stimulation (e.g. tapping on the
skin) may cause increasing pain with each tap and when the repetitive
stimulation stops, there may be a prolonged after-sensation of pain
(hyperpathia). There may be diffuse tenderness or point-tender spots in
the muscles of the affected region due to small muscle spasms called
muscle trigger points (myofascial pain syndrome). There may be
spontaneous sharp jabs of pain in the affected region that seem to come
from nowhere (paroxysmal dysesthesias and lancinating pains).
- Skin changes
- skin may appear shiny (dystrophy-atrophy), dry or scaly. Hair may
initially grow coarse and then thin. Nails in the affected extremity may
be more brittle, grow faster and then slower. Faster growing nails is
almost proof that the patient has RSD / CRPS. RSD / CRPS is associated
with a variety of skin disorders including rashes, ulcers and pustules. 9
Although extremely rare, some patients have required amputation of an
extremity due to life-threatening reoccurring infections of the skin.
Abnormal sympathetic (vasomotor changes) activity may be associated with
skin that is either warm or cold to touch. The patient may perceive
sensations of warmth or coolness in the affected limb without even
touching it (vasomotor changes). The skin may show increased sweating
(sudomotor changes) or increased chilling of the skin with goose flesh
(pilomotor changes). Changes in skin color can range from a white
mottled appearance to a red or blue appearance. Changes in skin color
(and pain) can be triggered by changes in the room temperature,
especially cold environments. However, many of these changes occur
without any apparent provocation. Patients describe their disease as
though it had a mind of its own.
Photo Gallery of Skin Lesions Associated with RSD / CRPS:
Dr. Robert J. Schwartzman, whose name is synonymous with RSD / CRPS,
has contributed a photo gallery to the Clinical Practice Guidelines. His
photos illustrate some of the objective findings that may be observed
in patients with RSD / CRPS. It should be
emphasized that patients with RSD / CRPS may not present with these
objective findings, especially during the early stages of the disease.
Dr. Schwartzman is Professor and Chairman of the
Department of Neurology at Hahnemann School of Medicine in Philadelphia,
PA, USA. He is a member the Scientific Advisory Committee. Through his
numerous publications, lectures, and research efforts, he shares his
clinical experience by making others aware of the effects of RSD / CRPS.
Dr. Schwartzman has received several honors and awards, including the
Mayo Clinic Neurology Teaching Award and the Dean's Special Award for
Excellence in Teaching from Hahnemann University of Medicine in both
1998 and 1999
RSD PHOTO GALLERY, PER RSD FOUNDATION:
|
Anchoring fibril deficiency. The patient sheds all of the skin from her arms and upper body. Stage III of RSD |
|
Atrophic reddened skin. Shiny skin that later desquamated. Stage III of RSD |
|
Atrophic skin of stage III patient Combination of loss of hair and increased thickness of hair |
|
Demonstrates brawny edema Reddened thickened skin Increased nail growth of the great toe Deep ulcerated lesion on the top of the foot. Stage I of RSD |
|
Example of atrophic skin with deep ulcer on the top of the right foot. Atrophic skin, loss of hair on the affected, or unaffected limb |
|
Example of Gardner-Diamond Syndrome |
|
Commonly seen small punctate skin lesions that will ulcerate Stage III of RSD |
|
Example of deep ulcer stage III. |
|
Ligature signs, bilaterally below the knees Nothing had been placed on the legs Stage III of RSD |
|
Example of early lesions that become ulcerated in latter stages. Stage I of RSD-yeah, doesn't itch either |
How BAD CAN it really get???
See the next post.
No comments:
Post a Comment